DOVONEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dovonex, and when can generic versions of Dovonex launch?
Dovonex is a drug marketed by Leo Pharma As and Leo Pharm and is included in three NDAs.
The generic ingredient in DOVONEX is calcipotriene. There are twelve drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the calcipotriene profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dovonex
A generic version of DOVONEX was approved as calcipotriene by FOUGERA PHARMS on May 6th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DOVONEX?
- What are the global sales for DOVONEX?
- What is Average Wholesale Price for DOVONEX?
Summary for DOVONEX
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 51 |
Clinical Trials: | 13 |
Patent Applications: | 5,629 |
Drug Prices: | Drug price information for DOVONEX |
What excipients (inactive ingredients) are in DOVONEX? | DOVONEX excipients list |
DailyMed Link: | DOVONEX at DailyMed |
![DOVONEX drug patent expirations Drug patent expirations by year for DOVONEX](/p/graph/s/t/DOVONEX-patent-expirations.png)
![Drug Prices for DOVONEX](/p/graph/drug-price/DOVONEX.png)
Recent Clinical Trials for DOVONEX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Cancer Institute (NCI) | Phase 2 |
Wake Forest University Health Sciences | Early Phase 1 |
Guangdong Provincial Hospital of Traditional Chinese Medicine | N/A |
Paragraph IV (Patent) Challenges for DOVONEX
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
DOVONEX | Topical Cream | calcipotriene | 0.005% | 020554 | 1 | 2009-12-02 |
DOVONEX | Topical Solution | calcipotriene | 0.005% | 020611 | 1 | 2006-05-19 |
US Patents and Regulatory Information for DOVONEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leo Pharma As | DOVONEX | calcipotriene | CREAM;TOPICAL | 020554-001 | Jul 22, 1996 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Leo Pharma As | DOVONEX | calcipotriene | OINTMENT;TOPICAL | 020273-001 | Dec 29, 1993 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Leo Pharm | DOVONEX | calcipotriene | SOLUTION;TOPICAL | 020611-001 | Mar 3, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DOVONEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Leo Pharm | DOVONEX | calcipotriene | SOLUTION;TOPICAL | 020611-001 | Mar 3, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Leo Pharma As | DOVONEX | calcipotriene | CREAM;TOPICAL | 020554-001 | Jul 22, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Leo Pharm | DOVONEX | calcipotriene | SOLUTION;TOPICAL | 020611-001 | Mar 3, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Leo Pharma As | DOVONEX | calcipotriene | CREAM;TOPICAL | 020554-001 | Jul 22, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Leo Pharma As | DOVONEX | calcipotriene | CREAM;TOPICAL | 020554-001 | Jul 22, 1996 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DOVONEX
See the table below for patents covering DOVONEX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 0679154 | ⤷ Sign Up | |
Singapore | 64192 | ⤷ Sign Up | |
Canada | 2151730 | NOUVELLE FORME CRISTALLINE D'UN ANALOGUE DE LA VITAMINE D (NEW CRYSTALLINE FORM OF A VITAMIN D ANALOGUE) | ⤷ Sign Up |
Japan | H08505612 | ⤷ Sign Up | |
Ireland | 861894 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |